Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
CADILAHC On Other Exchanges
CADILAHC is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

cadila healthcare ltd (CADILAHC) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

cadila healthcare ltd (CADILAHC) Related Businessweek News

No Related Businessweek News Found

cadila healthcare ltd (CADILAHC) Details

Cadila Healthcare Limited engages in the research, development, production, marketing, and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, veterinary, and human formulations. The company offers branded formulations in the therapeutic areas of neurological, neutraceutical, pain management, gastro intestinal, respiratory, anti-infective, biological, cardiovascular, female healthcare, dermatology, and others. It also provides consumer wellness products, such as Sugar Free, a low calorie sugar substitute; EverYuth, a range of skincare products; and Nutralite, a cholesterol free table spread. In addition, the company researches and develops a pipeline of 24 biologics comprising 20 biosimilars and 4 novel biological products; and new drugs in cardio-metabolic, inflammation, pain, and oncology therapeutic areas. Further, it provides animal healthcare products. Additionally, the company develops vaccines that are designed to address infectious diseases, including next-generation influenza, measles-mumps-rubella-varicella, typhoid, DPT-HiB, hepatitis-B, hepatitis-A, hepatitis-E, Japanese encephalitis, HPV, and combination vaccines. The company was founded in 1952 and is headquartered in Ahmedabad, India.

Founded in 1952

cadila healthcare ltd (CADILAHC) Top Compensated Officers

Chairman, Managing Director, Chairman of Shar...
Total Annual Compensation: 148.3M
Chief Financial Officer and Member of Risk Ma...
Total Annual Compensation: 25.6M
Deputy Managing Director, Director, Member of...
Total Annual Compensation: 100.0M
Compliance Officer and Company Secretary
Total Annual Compensation: 2.5M
Compensation as of Fiscal Year 2015.

cadila healthcare ltd (CADILAHC) Key Developments

Cadila Healthcare Limited Approves Alteration of Capital Clause of Memorandum of Association

Cadila Healthcare Limited approved the alteration of capital clause of Memorandum of Association in the postal ballot.

Cadila Healthcare Limited Approves Dividend for the Year 2014-2015

Cadila Healthcare Limited announced that at the AGM held on August 12, 2015, it has approved a dividend of INR 12 (@ 240%), aggregating to INR 2,456,982,240 on 204,748,520 equity shares of INR 5 each, be and is hereby declared and that the dividend shall be made payable to those members of the company whose names appear in the register of members of the company on August 12, 2015 in respect of members holding shares in physical from and as per list of beneficiaries provided by depositories as on book closure date with respect to the members holding shares in electronic form.

Cadila Healthcare Limited Proposes Amendments to Memorandum of Association

Cadila Healthcare Limited proposed to approve sub-division of equity shares and consequential amendments to capital clause of the Memorandum of Association by way of postal ballot.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDH:IN 425.65 INR +9.41

CADILAHC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cipla Ltd/India 664.00 INR +23.90
Glenmark Pharmaceuticals Ltd 1,057 INR +3.85
Piramal Enterprises Ltd 893.20 INR -23.00
Torrent Pharmaceuticals Ltd 1,570 INR -8.05
Wockhardt Ltd 1,586 INR +46.85
View Industry Companies

Industry Analysis


Industry Average

Valuation CADILAHC Industry Range
Price/Earnings 32.8x
Price/Sales 4.6x
Price/Book 9.8x
Price/Cash Flow 26.6x
TEV/Sales 4.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADILA HEALTHCARE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at